View Upcoming FDA Meetings, Conferences and Workshops

Cheminformatics Resources of U.S. Governmental Organizations 2026 Workshop Day 1: Monday, Jan. 5, 2026; 9 a.m. - 4:30 p.m. ET Day 2: Tuesday, Jan. 6, 2026; 9 a.m. - 4:30 p.m. ET Day 3: Wednesday, Jan. 7, 2026; 9 a.m. - 4:30 p.m. ET The purpose of the Cheminformatics Resources of U.S. Governmental Organizations 2026 Workshop is to enhance communication and collaboration between the U.S. Government-funded organizations that create and maintain databases, data standards, datasets, scientific approaches and computational resources dealing with chemical structures and properties of molecules and materials. Register Here: https://events.gcc.teams.microsoft.com/event/7b6ec524-19d5-46d8-85fc-adfcc5e70b0d@7d2fdb41-339c-4257-87f2-a665730b31fc/registration?utm_medium=email&utm_source=govdelivery Tobacco Products Scientific Advisory Committee Meeting Date: Thursday, Jan. 22, 2026; 9 a.m. - 4:30 p.m. ET Center for Tobacco Products’ TPSAC will meet virtually for an open session, during which the Committee will discuss modified risk tobacco product applications submitted by Swedish Match USA, Inc. for the following products, each available in two strengths (3 milligrams and 6 milligrams). Discussion will focus on evidence related to the relative health risks of the products, consumer understanding and perceptions of the applicant’s proposed modified risk claim, and the potential public health impact of a modified risk marketing order. Online Viewing: https://www.youtube.com/live/yrYtTTjlv8A Advancing the Development of Pediatric Therapeutics (ADEPT) 10: Addressing Challenges in Neonatal Product Development – Leveraging Rare Disease Frameworks Day 1: Thursday, Feb. 5, 2026; 1:30 - 5 p.m. ET Day 2: Friday, Feb. 6, 2026; 8:30 a.m. - 4 p.m. ET The FDA, in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (MCERSI), is announcing the following public workshop titled "Advancing the Development of Pediatric Therapeutics (ADEPT) 10: Addressing Challenges in Neonatal Product Development – Leveraging Rare Disease Frameworks." The aim of the public workshop is to discuss common challenges in neonatal and rare disease product development and identify opportunities to leverage rare disease product development frameworks in the neonatal product development space. Register Here: https://fda.zoomgov.com/webinar/register/WN_2f6E6U6HSzGdpgcUxC05Hg?utm_medium=email&utm_source=govdelivery#/registration Public Meeting: FDA Rare Disease Day 2026 Date: Monday, Feb. 23, 2026; 9 a.m. - 4 p.m. ET FDA will host Rare Disease Day, a virtual public meeting, on Monday, February 23, 2026 in global observance of Rare Disease Week. The theme is: “Moving Forward. Looking Ahead. An Event for Patients.” The goal of this year’s Rare Disease Day is to explore ways to engage and collaborate with patients and their communities to support and accelerate the development of medical products for rare diseases. We want patients to connect with FDA and stay involved with our outreach and engagement programs to ensure the patient voice informs medical product development and regulation throughout FDA. Register Here: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/public-meeting-fda-rare-disease-day-2026-02232026?utm_medium=email&utm_source=govdelivery